![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » CELEBREX CUTS RISK OF COLON POLYPS
CELEBREX CUTS RISK OF COLON POLYPS
The painkiller Celebrex nearly halves the chance of developing colon polyps but nearly doubles the risk of heart problems, say newly published studies that may rule out the drug's widespread use for preventing cancer.
The
Baltimore Sun
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct